Biomea Fusion, Inc. (BMEA)
2.03
+0.12
(+6.28%)
USD |
NASDAQ |
Sep 04, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Total Assets (Quarterly) : 36.87M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.87M |
| March 31, 2026 | 46.38M |
| December 31, 2025 | 58.57M |
| September 30, 2025 | 55.19M |
| June 30, 2025 | 73.16M |
| March 31, 2025 | 55.06M |
| December 31, 2024 | 79.94M |
| September 30, 2024 | 110.42M |
| June 30, 2024 | 136.16M |
| March 31, 2024 | 168.49M |
| December 31, 2023 | 199.93M |
| September 30, 2023 | 225.09M |
| Date | Value |
|---|---|
| June 30, 2023 | 248.67M |
| March 31, 2023 | 112.64M |
| December 31, 2022 | 129.84M |
| September 30, 2022 | 145.05M |
| June 30, 2022 | 161.74M |
| March 31, 2022 | 174.86M |
| December 31, 2021 | 186.32M |
| September 30, 2021 | 199.40M |
| June 30, 2021 | 209.53M |
| March 31, 2021 | 59.88M |
| December 31, 2020 | 62.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| REGENXBIO, Inc. | 386.62M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.74M |
| Shareholders Equity (Quarterly) | 12.14M |
| Debt to Equity Ratio | 0.0723 |
| Current Ratio | 3.475 |
| Net Debt Paydown Yield | 1.32% |